Phase I Study Of The Specific Endothelin A Receptor Antagonist Zibotentan (Zd4054) Combined With Docetaxel In Patients With Metastatic Castration-Resistant Prostate Cancer: Assessment Of Efficacy, Pain, And Safety
JOURNAL OF CLINICAL ONCOLOGY（2010）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要